Michael Gabriel

4.9k total citations · 1 hit paper
94 papers, 3.4k citations indexed

About

Michael Gabriel is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Gabriel has authored 94 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 34 papers in Oncology and 30 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Gabriel's work include Neuroendocrine Tumor Research Advances (35 papers), Neuroblastoma Research and Treatments (22 papers) and Radiopharmaceutical Chemistry and Applications (21 papers). Michael Gabriel is often cited by papers focused on Neuroendocrine Tumor Research Advances (35 papers), Neuroblastoma Research and Treatments (22 papers) and Radiopharmaceutical Chemistry and Applications (21 papers). Michael Gabriel collaborates with scholars based in Austria, Germany and United States. Michael Gabriel's co-authors include Irene Virgolini, Clemens Decristoforo, Dorota Kendler, Reto Bale, Christian Uprimny, Elisabeth von Guggenberg, Georg Dobrozemsky, Péter Kovács, Dirk Heute and Daniel Putzer and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of Surgery and Scientific Reports.

In The Last Decade

Michael Gabriel

87 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

2007 746 citations Michael Gabriel, Clemens Decristoforo et al. Journal of Nuclear Medicine profile →

Peers

Countries citing papers authored by Michael Gabriel

Since Specialization

Citations

This map shows the geographic impact of Michael Gabriel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gabriel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gabriel more than expected).

Fields of papers citing papers by Michael Gabriel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gabriel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gabriel. The network helps show where Michael Gabriel may publish in the future.

Co-authorship network of co-authors of Michael Gabriel

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gabriel. A scholar is included among the top collaborators of Michael Gabriel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gabriel. Michael Gabriel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Automated Production of [68Ga]Ga-Desferrioxamine B on Two Different Synthesis Platforms 2024 ·Pharmaceutics ·(unknown), Miloš Petřík, Christine Rangger, Michael Gabriel, Hubertus Haas, Bernhard Nilica, Irene Virgolini, Clemens Decristoforo	0
2	MRI and PET/CT in the assessment of lymph node metastases in head and neck cancer 2023 ·Scientific Reports ·(unknown), (unknown), Michael Gabriel, (unknown), (unknown), (unknown)	4
3	Personalized Thera(g)nostic Approach in Patients with Paraganglioma: Peptide Receptor Radionuclide Therapy 2021 ·Bernhard Nilica, (unknown), Christian Mair, Alexander Kroiss, Michael Gabriel, Irene Virgolini	1
4	The EANM guideline for radiosynoviorthesis 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Willm Uwe Kampen, (unknown), Manfréd M. Fischer, Michael Gabriel, R. Klett, Mark Konijnenberg, E. Kresnik, Henri Lellouche, F. Paycha, Lene Terslev, Cüneyt Türkmen, (unknown), Lidija Antunovic, Emmanouil Panagiotidis, Gopinath Gnanasegaran, Torsten Kuwert, Tim Van den Wyngaert	19
5	Association of adipocytokines serum levels with left atrial thrombus formation in atrial fibrillation patients on oral anticoagulation (Alert) – A cross-sectional study 2020 ·Nutrition Metabolism and Cardiovascular Diseases ·Hermann Blessberger, Patrick J. Mueller, Hisaki Makimoto, (unknown), (unknown), Christopher Gemein, (unknown), Christian W. Hamm, Thomas Deneke, (unknown), Andreas Mügge, Michael Gabriel, Clemens Steinwender	3
6	A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions 2020 ·Scientific Data ·Michael Gabriel, Vidal Fey, (unknown), (unknown), Kalle T. Rytkönen, (unknown), Kaisa Huhtinen, Teemu D. Laajala, Harri Siitari, Arho Virkki, Pia Suvitie, Harry Kujari, Tero Aittokallio, Antti Perheentupa, Matti Poutanen	38
7	Radionuklidtherapie von Knochenmetastasen mittels Radium-223 2016 ·Nuklearmedizin - NuclearMedicine ·Michael Andreeff, Alexander Becherer, Andreas Bockisch, E. Fricke, Lilli Geworski, Alexander Heinzel, Bernd J. Krause, Thomas Krause, Markus Mitterhauser, Klemens Scheidhauer, M. Schenck, Wilfried Sonnenschein, Michael Gabriel, Thorsten Pöppel	3
8	Clinical Usefulness of a Novel Freehand 3D Imaging Device for Radio-Guided Intraoperative Sentinel Lymph Node Detection in Malignant Melanoma 2015 ·Clinical Nuclear Medicine ·(unknown), Markus Klinger, (unknown), (unknown), Andreas Shamiyeh, (unknown), Patrick M. Colletti, Domenico Rubello, Michael Gabriel	14
9	First Experience Using Peptide Receptor Radionuclide Therapy in a Patient With Urothelial Carcinoma 2013 ·Clinical Nuclear Medicine ·Daniel Putzer, Michael Gabriel, Rupert Prommegger, Dorota Kendler, Irene Virgolini	1
10	[ ^99m Tc]Demotensin VI: Biodistribution and Initial Clinical Results in Tumor Patients of a Pilot/Phase I Study 2011 ·Cancer Biotherapy and Radiopharmaceuticals ·Michael Gabriel, Clemens Decristoforo, Ewald Wöll, Wolfgang Eisterer, Berthold A. Nock, Θεοδοσία Μάινα, Roy Moncayo, Irene Virgolini	13
11	Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Irene Virgolini, Valentina Ambrosini, Jamshed Bomanji, Richard P. Baum, Stefano Fanti, Michael Gabriel, Νικόλαος Παπαθανασίου, Giovanna Pepe, Wim J.G. Oyen, (unknown), Arturo Chiti	312
12	Virtual Neck Exploration 2009 ·Annals of Surgery ·Rupert Prommegger, (unknown), Christoph Profanter, (unknown), Michael Sieb, Péter Kovács, Reto Bale, Daniel Putzer, Michael Gabriel, Raimund Margreiter	38
13	Bone Metastases in Patients with Neuroendocrine Tumor: ⁶⁸Ga-DOTA-Tyr³-Octreotide PET in Comparison to CT and Bone Scintigraphy 2009 ·Journal of Nuclear Medicine ·Daniel Putzer, Michael Gabriel, Benjamin Henninger, Dorota Kendler, Christian Uprimny, Georg Dobrozemsky, Clemens Decristoforo, Reto Bale, Werner Jaschke, Irene Virgolini	159
14	99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours 2007 ·European Journal of Nuclear Medicine and Molecular Imaging ·Elisabeth von Guggenberg, H. Dietrich, Ira Skvortsova, Michael Gabriel, Irene Virgolini, Clemens Decristoforo	37
15	68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT breakdown → 2007 ·Journal of Nuclear Medicine ·Michael Gabriel, Clemens Decristoforo, Dorota Kendler, Georg Dobrozemsky, Dirk Heute, Christian Uprimny, Péter Kovács, Elisabeth von Guggenberg, Reto Bale, Irene Virgolini	746
16	Evidence for Somatostatin receptor 2 in thyroid tissue 2006 ·Regulatory Peptides ·(unknown), Christoph Schwarzer, Christian Ensinger, Michael Gabriel, Rupert Prommegger, G Riccabona, Clemens Decristoforo	35
17	^99m Tc-N ₄ -[Tyr ³ ]Octreotate Versus ^99m Tc-EDDA/HYNIC-[Tyr ³ ]Octreotide: An Intrapatient Comparison of Two Novel Technetium-99m Labeled Tracers for Somatostatin Receptor Scintigraphy 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Michael Gabriel, Clemens Decristoforo, Θεοδοσία Μάινα, Berthold A. Nock, Elisabeth von Guggenberg, Paul Cordopatis, Roy Moncayo	24
18	Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas. 2003 ·PubMed ·Christian Ensinger, Rupert Prommegger, (unknown), Michael Gabriel, Gilbert Spizzo, Gregor Mikuz, (unknown)	4
19	Comparison of clinical valence of 99m Tc-HYNIC-TOC with 111 In-DTPA-Octreotide in oncological diagnostics of somatostatin-receptor-positive tumours 2002 ·Michael Gabriel, Clemens Decristoforo, E. Donnemiller, Hanno Ulmer, (unknown), (unknown), Roy Moncayo	10
20	Stressfrakturen bei Athleten 2002 ·Der Radiologe ·(unknown), (unknown), Helen E. Gruber, Michael Gabriel, (unknown), (unknown), Werner Jaschke	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact